2005
DOI: 10.1016/j.healun.2004.05.024
|View full text |Cite
|
Sign up to set email alerts
|

Lung Transplantation Outcome in Cystic Fibrosis Patients With Previous Pneumothorax

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
25
0
1

Year Published

2009
2009
2019
2019

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(27 citation statements)
references
References 19 publications
1
25
0
1
Order By: Relevance
“…[1][2][3][4][5] Because of this trend, cardiothoracic surgeons are now experiencing increased numbers of adult CF patients presenting for lung transplantation (LTx).…”
mentioning
confidence: 99%
“…[1][2][3][4][5] Because of this trend, cardiothoracic surgeons are now experiencing increased numbers of adult CF patients presenting for lung transplantation (LTx).…”
mentioning
confidence: 99%
“…Six relevant studies evaluating lung transplant outcomes following pleurodesis in specific populations were returned, two of which address the issue in patients with a history of cystic fibrosis, and three of which focus on patients with lymphangioleiomyomatosis-two lung diseases with a predilection for recurrent pneumothoraces. [1][2][3][4][5] An UpToDate search with similar keywords yielded general guidelines for lung transplant recipient selection, including special considerations such as previous cardiothoracic surgery. One cited article was a consensus for the selection of lung transplant candidates from the Pulmonary Transplantation Council of the International Society of Heart and Lung Transplantation, which lead to discovery of two additional large-volume, single-institution studies on lung transplantation in patients having previously undergone cardiothoracic surgical procedures.…”
Section: Related Literaturementioning
confidence: 99%
“…Experienced centres review cases on an individual basis. 9,15 Collagen vascular/connective tissue disease These patients remain controversial due to the concerns that extrapulmonary manifestations of disease might increase the risks of complications, particularly the increased oesophageal dysmotility associated with scleroderma. However, several studies have shown that in selected patients with scleroderma, 1-and 2-year survival is comparable with other groups.…”
Section: Prior Thoracic Surgery and Pleurodesismentioning
confidence: 99%